A Randomized Trial Evaluating the Safety Profile of Sugammadex in High Surgical Risk ASA Physical Class 3 or 4 Participants

W. Joseph Herring; Yuki Mukai; Aobo Wang; Jeannine Lutkiewicz; John F. Lombard; Li Lin; Molly Watkins; David M. Broussard; Manfred Blobner


BMC Anesthesiol. 2021;21(259) 

In This Article


In conclusion, the results of this study support the overall favorable safety profile, inclusive of cardiac safety parameters, of sugammadex for reversal of rocuronium- or vecuronium-induced moderate and deep neuromuscular block in ASA Class 3 or 4 participants.